Acute Sinusitis Market Research Report - Forecast to 2027

Acute Sinusitis Market Information: By Diagnosis (Nasal Endoscopy, Imaging Test, Laboratory Test, Allergy Testing), Treatment (Saline Nasal Spray, Nasal Corticosteroids, Decongestants, OTC Pain Relievers), End-User (Hospitals)- Global Forecast till 2027

ID: MRFR/Pharma/4371-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Synopsis


Also known as acute rhinosinusitis, acute sinusitis is a short-term inflammation of the membranes lining the nose and surrounding sinuses. There are various causes of acute sinusitis such as intranasal allergies, hay fever, nasal polyps, infected adenoids, deviated nasal septum, and cystic fibrosis. Symptoms of acute sinusitis include nasal congestion, sore throat, cough, headache, bad breath, pressure, or tenderness behind your eyes, nose, cheeks, or forehead, toothache, and many others. Diagnosis of the disease can be made using various tests such as nasal endoscopy, imaging tests such as MRI and CT scan, and allergy testing. The treatment of acute sinusitis includes the use of the saline nasal spray, nasal corticosteroids, decongestants, OTC pain relievers, allergy shots, antibiotics, and others. As per the American Academy of Otolaryngology, acute sinusitis is common and mainly affects around 1 in 8 adults per year.


The increasing number of patients suffering from acute sinusitis, rising number of diagnostic tests, and increasing number of players manufacturing drugs for the treatment of acute sinusitis are the major factors contributing to the growth of the market. Furthermore, the increasing use of medical devices for diagnosis and treatment of diseases and the use of various medications for the treatment such as nasal sprays, nasal corticosteroids, and decongestants are also expected to accelerate the growth of the market during the forecast period. However, unawareness about sinusitis, its diagnosis, and treatment also fuel the growth of the market.


Global acute sinusitis market is expected to grow at a CAGR of 6.2% during the forecast period.


Segments  


The global acute sinusitis market is segmented on the basis of diagnosis, treatment, and end-user.


On the basis of diagnosis, the market is segmented into nasal endoscopy, imaging tests, laboratory tests, and allergy testing. Imaging tests are further segmented into CT scan and MRI.


On the basis of treatment, the market is segmented into saline nasal spray, nasal corticosteroids, decongestant, OTC pain relievers, allergy shots, antibiotics, and others.


On the basis of end-user, the market is segmented into hospitals and clinics, research centers, and others.


FIGURE 1: Global Acute Sinusitis Market, by Region, 2016 (%)


 Acute Sinusitis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Intended Audience



  • Pharmaceutical and biotechnology companies

  • Medical research laboratories

  • Research and Development (R&D) companies

  • Market research and consulting service providers

  • Potential investors


Research Methodology


 Acute Sinusitis Methodology


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Regional Analysis of the Global Acute Sinusitis Market                      


The Americas leads the global acute sinusitis market with North America being the largest. The rising prevalence of chronic diseases in the U.S. and technological advancements in diagnostic testing fuel the growth of the market in North America. According to the Center for Disease Control and Prevention (CDC), in the U.S., 29.4 million people suffer from acute sinusitis. Additionally, there is an increase in the direct spending by the U.S. population for sinusitis management including medications, outpatient and emergency department visits, and ancillary tests and procedures.


Europe is the second largest market for acute sinusitis. The increasing demand for laboratory test and allergy testing, with an increase in various types of laboratory testing fuel the growth of the market. Furthermore, there are various other factors driving the growth of the market such as increasing focus on diagnostic testing for both acute and chronic illnesses and increasing expenditure on research and development activities by countries such as Germany, France and the U.K. Additionally, the increasing focus on development of innovative technologies and overall growth of healthcare diagnostics in this region also contribute to the growth of the market.


The Asia Pacific acute sinusitis market is expected to exhibit a huge growth potential which is mainly driven by the increasing awareness about acute sinusitis and the increasing demand for a skin test for its diagnosis. Furthermore, the increasing demand for laboratory testing devices and a huge development in the medical device sector fuel the growth of the market in this region. Additionally, the market is also driven by the increasing focus of key players on targeting major geographies in Asia Pacific such as India, Australia, and the Republic of Korea. Additionally, the increasing number of patients suffering from acute sinusitis and the availability of various treatment options for the disease drive the growth of the market.  India, China, and Japan are the major contributors to the growth of the market due to an increase in the number of healthcare institutes such as hospitals and clinics and availability of skilled workforce.


In the Middle East, the market is mainly driven by the increasing importance of diagnosis and treatment for sinusitis and the growth of the healthcare industry in countries such as the United Arab Emirates (U.A.E.) and Saudi Arabia. In Africa, the demand for primary care services and the increasing prevalence of acute and chronic diseases are the major factors driving the market growth.


Key Players in the Global Acute Sinusitis Market        


Some of the key players in this market are Sanofi (France), Abbott (U.S.), Bayer AG (U.S.), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Merck & Co, Inc. (U.S.), AstraZeneca Plc (U.K), Reddy’s Lab (India), Novartis AG (Germany), and others.



Frequently Asked Questions (FAQ) :


Acute Sinusitis Market is projected to grow at a 6.2% CAGR between 2020-2027.

The Americas is expected to lead the Acute Sinusitis Market.

Rising prevalence of acute sinusitis and increasing number of diagnostic tests are adding market growth.

Unawareness about sinusitis may limit market growth.

End users of Acute Sinusitis Market include research centers and hospitals & clinics.